Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura

ONCOLOGY

Volumn 23, Issue 13, 2009, Pages

  Dmytrijuk, Andrew ^a   Robie Suh, Kathy ^a   Rieves, Dwaine ^a   Pazdur, Richard ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; ELTROMBOPAG; IMMUNOGLOBULIN; PLACEBO; RETICULIN; RHESUS D ANTIBODY; RITUXIMAB;

ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPENIA; DOUBLE BLIND PROCEDURE; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIVER FUNCTION TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPLENECTOMY; THROMBOCYTOPENIA;

EID: 73449098614     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bussel JB, Cheng G, Saleh MN, et al: Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 357:2237-2247, 2007.
2. Stevens W, Koene H, Zwaginga JJ, et al: Chronic idiopathic thrombocytopenic purpura: Present strategy, guidelines and new insights. Netherland J Med 64:356-363, 2006.
3. Cines DB, Bussel JB, Liebman HA: The ITP syndrome: Pathogenic and clinical diversity. Blood 113:6511-6521, 2009.
4. Neylon AJ, Saunders PW, Howard MR, et al: Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: A prospective study of a population-based cohort of 245 patients. Br J Haematol 112:966-974, 2003.
5. Cohen YC, Djulbegovic B, Shamai-Lubovitz O, et al: The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 160:1630-1638, 2000.
6. Mueller-Eckhardt C: Idiopathic thrombocytopenic purpura (ITP); clinical and immunologic considerations. Semin Thromb Hemost 3:125-159, 1997.
7. McCrae KR, Bussel JB, Mannucci PM, et al: Platelets: An update on diagnosis and management of thrombocytopenic disorders. Hematology Am Soc Hematol Educ Program 282-305, 2001.
8. ASH ITP Practice Guidelines Panel: Diagnosis and treatment of idiopathic thrombocytopenic purpura: Recommendations of the American Society of Hematology. Ann Intern Med 126:319-326, 1997.
9. Bussel JB, Graziano JN, Kimberly RP, et al: Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity and mechanism of effect. Blood 77:1884-1893, 1991.
10. Gurcan HM, Keskin DB, Stern JN, et al: A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 9:10-25, 2009.
11. Aledort LM, Hayward CP, Chen MG, et al: Prospective screening of 205 patients with ITP, including diagnosis, serological markers and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. Am J Hematol 76:205-213, 2004.
12. Parker RI, Siegel RS, Ratajczak MZ, et al: Deficient in vitro megakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia. J Pediatr Hematol Oncol 20:196-201, 1998.
13. Bussel JB, Kuter DJ, Pullarkat V, et al: Safety and efficacy of long term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood 113:2161-2171, 2009.
14. Kuter DJ, Bussel JB, Lyons RM, et al: Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomized controlled trial. Lancet 371:395-403, 2008.
15. Bussel JB, Cheng G, Saleh MN, et al: Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 357:2237-2247, 2007.
16. Cines DB, Blanchette VS: Immune thrombocytopenic purpura. N Engl J Med 346:995-1008, 2002.
17. Page LK, Psaila B, Provan D, et al: The immune thrombocytopenic purpura (ITP) bleeding score: Assessment of bleeding in patients with ITP. Br J Haematol 138:245-248, 2007.
18. British Committee for Standards in Hematology, General Hematology Task Force: Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120:574-596, 2003.